Cargando…

Phospholipase D1 deficiency in mice causes nonalcoholic fatty liver disease via an autophagy defect

Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of triglycerides (TG) as lipid droplets in the liver. Although lipid-metabolizing enzymes are considered important in NAFLD, the involvement of phospholipase D1 (PLD1) has not yet been studied. Here, we show that the genet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hur, Jang Ho, Park, Shi-Young, Dall’Armi, Claudia, Lee, Jae Sung, Di Paolo, Gilbert, Lee, Hui-Young, Yoon, Mee-Sup, Min, Do Sik, Choi, Cheol Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156943/ https://www.ncbi.nlm.nih.gov/pubmed/27976696 http://dx.doi.org/10.1038/srep39170

Ejemplares similares

Regulation of Mammalian Autophagy by Class II and III PI 3-Kinases through PI3P Synthesis
por: Devereaux, Kelly, et al.
Publicado: (2013)

MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins
por: Colecchia, David, et al.
Publicado: (2012)

Robot-aided therapy for upper limbs in patients with stroke-related lesions. Brief report of a clinical experience
por: Bovolenta, Federica, et al.
Publicado: (2011)

The hydrophobic amino acids involved in the interdomain association of phospholipase D1 regulate the shuttling of phospholipase D1 from vesicular organelles into the nucleus
por: Jang, Young Hoon, et al.
Publicado: (2012)

The sense-of-coherence predicts health-related quality of life and emotional distress but not disability in Parkinson’s disease
por: Gison, Annalisa, et al.
Publicado: (2014)

Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy
por: Jang, Hyun-Jun, et al.
Publicado: (2023)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Arf6 controls retromer traffic and intracellular cholesterol distribution via a phosphoinositide-based mechanism
por: Marquer, Catherine, et al.
Publicado: (2016)

Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease
por: Kim, Young Seok, et al.
Publicado: (2013)

Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
por: Barbanti, Piero, et al.
Publicado: (2012)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Han, Man-Hoon, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease
por: Jung, Eun Sun, et al.
Publicado: (2016)

Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver disease
por: Lee, Seungwoo, et al.
Publicado: (2017)

Inhibition of phospholipase D2 induces autophagy in colorectal cancer cells
por: Hwang, Won Chan, et al.
Publicado: (2014)

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Serum Adipocyte Fatty Acid–Binding Protein Levels Are Associated With Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
por: Koh, Jang Hyun, et al.
Publicado: (2009)

Sphingomyelin synthase–related protein SMSr is a phosphatidylethanolamine phospholipase C that promotes nonalcoholic fatty liver disease
por: Chiang, Yeun-po, et al.
Publicado: (2023)

Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
por: Park, Kyung Sik, et al.
Publicado: (2004)

Association of Serum Adipocyte-Specific Fatty Acid Binding Protein with Fatty Liver Index as a Predictive Indicator of Nonalcoholic Fatty Liver Disease
por: Jeon, Won Seon, et al.
Publicado: (2013)

Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease
por: Kim, Min Cheol, et al.
Publicado: (2019)

The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease
por: Kim, Yumi, et al.
Publicado: (2021)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Population
por: Cho, Young Hoon, et al.
Publicado: (2019)

THU072 Association Between Nonalcoholic Fatty Liver Disease And Growth Hormone Deficiency In Patients With Nonfunctioning Pituitary Adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease
por: Yoon, Dokyoung, et al.
Publicado: (2005)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao, Yuqing, et al.
Publicado: (2016)

KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure
por: Jang, Ju-hong, et al.
Publicado: (2022)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials
por: Giannetta, Elisa, et al.
Publicado: (2014)

Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy
por: Song, Youngmi, et al.
Publicado: (2023)

Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Hepatoprotective Effect and Synergism of Bisdemethoycurcumin against MCD Diet-Induced Nonalcoholic Fatty Liver Disease in Mice
por: Kim, Sung-Bae, et al.
Publicado: (2016)

Rationale and clinical benefits of an intensive long-term pulmonary rehabilitation program after oesophagectomy: preliminary report
por: Lococo, Filippo, et al.
Publicado: (2012)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_djdbgi2giq98fn4tj1lsm655fe